$TRNS
TRANSCAT INC

2020 Q3 Form 10-Q Financial Statement

#000120677420003015 Filed on November 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3
Revenue $41.61M $41.76M
YoY Change -0.37% 7.42%
Cost Of Revenue $30.11M $31.32M
YoY Change -3.85% 5.31%
Gross Profit $11.49M $10.45M
YoY Change 10.04% 14.28%
Gross Profit Margin 27.63% 25.01%
Selling, General & Admin $8.416M $7.386M
YoY Change 13.95% 6.12%
% of Gross Profit 73.22% 70.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.870M $1.680M
YoY Change 11.31% 12.0%
% of Gross Profit 16.27% 16.08%
Operating Expenses $8.416M $7.386M
YoY Change 13.95% 6.12%
Operating Profit $3.078M $3.059M
YoY Change 0.62% 40.32%
Interest Expense -$230.0K -$240.0K
YoY Change -4.17% 20.0%
% of Operating Profit -7.47% -7.85%
Other Income/Expense, Net -$317.0K -$297.0K
YoY Change 6.73%
Pretax Income $2.761M $2.762M
YoY Change -0.04% 39.49%
Income Tax $737.0K $383.0K
% Of Pretax Income 26.69% 13.87%
Net Earnings $2.024M $2.379M
YoY Change -14.92% 59.66%
Net Earnings / Revenue 4.86% 5.7%
Basic Earnings Per Share $0.27 $0.32
Diluted Earnings Per Share $0.27 $0.32
COMMON SHARES
Basic Shares Outstanding 7.417M shares 7.331M shares
Diluted Shares Outstanding 7.549M shares 7.484M shares

Balance Sheet

Concept 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.000M $900.0K
YoY Change 11.11% 50.0%
Cash & Equivalents $962.0K $920.0K
Short-Term Investments
Other Short-Term Assets $2.400M $2.400M
YoY Change 0.0% 100.0%
Inventory $13.69M $15.30M
Prepaid Expenses
Receivables $27.65M $26.70M
Other Receivables $717.0K $1.000M
Total Short-Term Assets $45.38M $46.30M
YoY Change -1.99% 11.3%
LONG-TERM ASSETS
Property, Plant & Equipment $21.48M $28.60M
YoY Change -24.91% 45.92%
Goodwill $41.77M
YoY Change
Intangibles $6.737M
YoY Change
Long-Term Investments
YoY Change
Other Assets $685.0K $800.0K
YoY Change -14.38% -11.11%
Total Long-Term Assets $80.68M $68.70M
YoY Change 17.44% 12.99%
TOTAL ASSETS
Total Short-Term Assets $45.38M $46.30M
Total Long-Term Assets $80.68M $68.70M
Total Assets $126.1M $115.0M
YoY Change 9.62% 12.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.06M $11.10M
YoY Change -0.41% -13.95%
Accrued Expenses $7.100M $6.300M
YoY Change 12.7% 21.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.024M $1.900M
YoY Change 6.53% -9.52%
Total Short-Term Liabilities $20.64M $19.40M
YoY Change 6.37% -6.73%
LONG-TERM LIABILITIES
Long-Term Debt $20.71M $22.70M
YoY Change -8.77% -2.16%
Other Long-Term Liabilities $3.345M $7.800M
YoY Change -57.12% 310.53%
Total Long-Term Liabilities $24.05M $30.50M
YoY Change -21.13% 21.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.64M $19.40M
Total Long-Term Liabilities $24.05M $30.50M
Total Liabilities $55.96M $52.30M
YoY Change 6.99% 10.11%
SHAREHOLDERS EQUITY
Retained Earnings $48.62M
YoY Change
Common Stock $22.17M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $70.10M $62.66M
YoY Change
Total Liabilities & Shareholders Equity $126.1M $115.0M
YoY Change 9.62% 12.3%

Cashflow Statement

Concept 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $2.024M $2.379M
YoY Change -14.92% 59.66%
Depreciation, Depletion And Amortization $1.870M $1.680M
YoY Change 11.31% 12.0%
Cash From Operating Activities $8.440M $1.960M
YoY Change 330.61% 8.29%
INVESTING ACTIVITIES
Capital Expenditures -$1.860M -$2.600M
YoY Change -28.46% 46.07%
Acquisitions
YoY Change
Other Investing Activities -$930.0K
YoY Change -74.24%
Cash From Investing Activities -$1.860M -$3.540M
YoY Change -47.46% -34.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.700M 1.830M
YoY Change -411.48% -52.09%
NET CHANGE
Cash From Operating Activities 8.440M 1.960M
Cash From Investing Activities -1.860M -3.540M
Cash From Financing Activities -5.700M 1.830M
Net Change In Cash 880.0K 250.0K
YoY Change 252.0% 8.7%
FREE CASH FLOW
Cash From Operating Activities $8.440M $1.960M
Capital Expenditures -$1.860M -$2.600M
Free Cash Flow $10.30M $4.560M
YoY Change 125.88% 27.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Revenues
Revenues
41607000 USD
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7549000 shares
us-gaap Revenues
Revenues
80511000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31318000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
30113000 USD
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7434646 shares
us-gaap Gross Profit
GrossProfit
20903000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
11494000 USD
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
59608000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
63661000 USD
us-gaap Gross Profit
GrossProfit
20497000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
10445000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4291000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4231000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20833000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
41773000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
41540000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21475000 USD
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7432582 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7432582 shares
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3303000 USD
dei Entity File Number
EntityFileNumber
000-03905
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6777000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2762000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3482000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4435000 USD
dei Entity Registrant Name
EntityRegistrantName
TRANSCAT, INC.
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-240000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
47000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
979000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
938000 USD
us-gaap Net Income Loss
NetIncomeLoss
4097000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-68000 USD
dei Entity Central Index Key
EntityCentralIndexKey
0000099302
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-28
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8365000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2761000 USD
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7484000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7441000 shares
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2024000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8197000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
474000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1372000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1287000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2822000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8424000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2210000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-473000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-112000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
463000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
132000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
788000 USD
us-gaap Interest Paid Net
InterestPaidNet
466000 USD
us-gaap Interest Paid Net
InterestPaidNet
491000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
332000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
688000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
59630000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
369000 USD
CY2019Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1346000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
203000 USD
CY2019Q2 trns Other Comprehensive Income Loss Net Of Taxes
OtherComprehensiveIncomeLossNetOfTaxes
129000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
1718000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
60703000 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1003000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1476000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
102000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2019Q3 us-gaap Revenues
Revenues
41763000 USD
us-gaap Revenues
Revenues
84158000 USD
us-gaap Operating Expenses
OperatingExpenses
16861000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8496000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8703000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4125000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3155000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
8416000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7293000 shares
us-gaap Operating Expenses
OperatingExpenses
15480000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
us-gaap Operating Income Loss
OperatingIncomeLoss
5017000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-317000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7417000 shares
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
737000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
383000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
660000 USD
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2024000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
7386000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-297000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
2379000 USD
us-gaap Net Income Loss
NetIncomeLoss
4097000 USD
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7331000 shares
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3078000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-560000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3059000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
338000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4042000 USD
us-gaap Net Income Loss
NetIncomeLoss
2822000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-582000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7405000 shares
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6737000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7977000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4171000 USD
CY2020Q3 us-gaap Cash
Cash
962000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
74000 USD
CY2020Q1 us-gaap Cash
Cash
499000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-66000 USD
CY2020Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
717000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
2379000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
685000 USD
CY2020Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1132000 USD
us-gaap Net Income Loss
NetIncomeLoss
2822000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
719000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
13685000 USD
us-gaap Net Income Loss
NetIncomeLoss
4097000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2189000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
14180000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
589000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
253000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2369000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1697000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
45380000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
48460000 USD
CY2020Q3 us-gaap Assets
Assets
126060000 USD
CY2020Q1 us-gaap Assets
Assets
128122000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2323000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3150000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
480000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
165000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
128000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10010000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8593000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27647000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
30952000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-56000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
328000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7525000 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
46000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
37000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
10000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
75000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
28000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1894000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
55958000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
61035000 USD
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
523000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
201000 USD
trns Payment Of Contingent Consideration For Business Acquisition
PaymentOfContingentConsiderationForBusinessAcquisition
USD
trns Payment Of Contingent Consideration For Business Acquisition
PaymentOfContingentConsiderationForBusinessAcquisition
484000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3116000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4800000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-6632000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
4598000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
962000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
920000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
46477000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3736000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
20635000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
20922000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20709000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
184000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
28362000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3072000 USD
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7381180 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7381180 shares
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11055000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
11947000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
18453000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
17929000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7118000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-682000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6907000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1010000 USD
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
438000 USD
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
86000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
48615000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
70102000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
67087000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
452000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2024000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1982000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6832000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3345000 USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
3716000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
3691000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3025000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
126060000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128122000 USD
us-gaap Net Income Loss
NetIncomeLoss
2822000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
625000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1149000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-892000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3433000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-236000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12476000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2834000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3116000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4048000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
678000 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-3543000 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-778000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-623000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
807000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1626000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-475000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
327000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
305000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
499000 USD
CY2020Q3 trns Other Comprehensive Income Loss Net Of Taxes
OtherComprehensiveIncomeLossNetOfTaxes
165000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2024000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
70102000 USD
CY2019Q3 trns Other Comprehensive Income Loss Net Of Taxes
OtherComprehensiveIncomeLossNetOfTaxes
-55000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
2379000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
62656000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
67087000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
383000 USD
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1287000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
312000 USD
CY2020Q2 trns Other Comprehensive Income Loss Net Of Taxes
OtherComprehensiveIncomeLossNetOfTaxes
163000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
798000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
67456000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
91000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
366000 USD
CY2020Q3 us-gaap Investments
Investments
400000 USD
CY2020Q1 us-gaap Investments
Investments
400000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-100000 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-100000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-100000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-100000 USD
CY2020Q3 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
4500000 USD
trns Dilutive Securities Effect Per Share On Earnings
DilutiveSecuritiesEffectPerShareOnEarnings
trns Dilutive Securities Effect Per Share On Earnings
DilutiveSecuritiesEffectPerShareOnEarnings
-0.01
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7417000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7331000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7405000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7293000 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
132000 shares
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
153000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
120000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
148000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7549000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7484000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7525000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7441000 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
38000 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
56000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25000 shares
CY2020Q3 trns Estimated Value Of Assets And Liabilities
EstimatedValueOfAssetsAndLiabilities
8000000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1700000 USD
trns Leverage Ratio Of Debt
LeverageRatioOfDebt
1.19 pure
CY2020 trns Leverage Ratio Of Debt
LeverageRatioOfDebt
1.53 pure
trns Discrete Benefits Related To Sharebased Compensation Awards
DiscreteBenefitsRelatedToSharebasedCompensationAwards
300000 USD
trns Discrete Benefits Related To Sharebased Compensation Awards
DiscreteBenefitsRelatedToSharebasedCompensationAwards
800000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
150000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.63
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
20000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
27.48
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.00
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Other Increases Decreases In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
145000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.86
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1787000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
90000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
17.01
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
1524000 USD
CY2020Q3 us-gaap Revenues
Revenues
41607000 USD
CY2019Q3 us-gaap Revenues
Revenues
41763000 USD
us-gaap Revenues
Revenues
80511000 USD
us-gaap Revenues
Revenues
84158000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
11494000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
10445000 USD
us-gaap Gross Profit
GrossProfit
20903000 USD
us-gaap Gross Profit
GrossProfit
20497000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
8416000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
7386000 USD
us-gaap Operating Expenses
OperatingExpenses
16861000 USD
us-gaap Operating Expenses
OperatingExpenses
15480000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3078000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3059000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4042000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
5017000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-317000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-297000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-560000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-582000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
737000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
383000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
660000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
338000 USD
CY2020Q3 us-gaap Other General Expense
OtherGeneralExpense
1054000 USD
CY2019Q3 us-gaap Other General Expense
OtherGeneralExpense
680000 USD
us-gaap Other General Expense
OtherGeneralExpense
1220000 USD
us-gaap Other General Expense
OtherGeneralExpense
920000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2024000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
2379000 USD
us-gaap Net Income Loss
NetIncomeLoss
2822000 USD
us-gaap Net Income Loss
NetIncomeLoss
4097000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
88018000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
4313000 USD
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.62
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.61

Files In Submission

Name View Source Status
0001206774-20-003015-index-headers.html Edgar Link pending
0001206774-20-003015-index.html Edgar Link pending
0001206774-20-003015.txt Edgar Link pending
0001206774-20-003015-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
transcat3825151-10q.htm Edgar Link pending
transcat3825151-10q_htm.xml Edgar Link completed
transcat3825151-ex311.htm Edgar Link pending
transcat3825151-ex312.htm Edgar Link pending
transcat3825151-ex321.htm Edgar Link pending
trns-20200926.xsd Edgar Link pending
trns-20200926_cal.xml Edgar Link unprocessable
trns-20200926_def.xml Edgar Link unprocessable
trns-20200926_lab.xml Edgar Link unprocessable
trns-20200926_pre.xml Edgar Link unprocessable